-
New Mexico Public Employees Retirement Association Solvency Analysis
PERA administrators and stakeholders are likely to face persistent challenges made more pronounced by ongoing market and revenue volatility.
-
Do Marijuana License Fees Help Keep the Black Market Going?
Marijuana fees are much higher than most alcohol license fees in each respective state.
-
Why Florida Should Shift from Gas Taxes to Per-Mile User Fees— and How to Do It
This policy brief focuses on how Florida policymakers can address the looming highway-funding problem by transitioning from per-gallon taxes to per-mile charges.
-
How Much Gas Tax Money States Divert Away From Roads
Examining the percentage of state gas tax revenue that is allocated for expenses unrelated to roads, including money shifted to law enforcement, education, tourism, environmental programs and more.
-
Mississippi Public Employees’ Retirement System Solvency Analysis
Underperforming investment returns have been the biggest contributor to the growing unfunded liability, adding $6.8 billion in debt to the system since 2001.
-
Marijuana Business Insurance: Another Hurdle For Entrepreneurs
The current regulatory landscape has resulted in business owners who are hesitant to purchase insurance and few companies willing to provide insurance.
-
Answering Frequently Asked Questions About COVID-19 and Public Pensions
This resource, designed for state legislators and staff, will assist in answering crucial questions regarding how the pandemic and resulting market conditions have affected state sponsored public pension plans.
-
Working Paper: Does Compulsory Schooling Affect Innovation? Evidence from the United States
We consider how the initial adoption of compulsory schooling affected state-level rates of patenting and real output per worker, finding declines in both once the originally affected cohorts reach middle age.
-
Frequently Asked Questions About Chloroquine and Hydroxychloroquine In Treating Covid-19
Our approaches to defeating the coronavirus should be given the greatest degree of regulatory freedom possible, leaving life and death treatment options to the physicians and their patients.